Neurocrine Biosciences Inc (NASDAQ:NBIX)

106.90
BATS BZX Real-Time Price
As of 11:06am ET
 -3.31 / -3.00%
Today’s Change
75.25
Today|||52-Week Range
129.29
-10.50%
Year-to-Date

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 131.00, with a high estimate of 165.37 and a low estimate of 101.00. The median estimate represents a +22.54% increase from the last price of 106.90.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.12
Sales
$408.9M
Reporting Date
Feb 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 62.33%
 
 
 
 
 
 
Growthannually 141.02%
 
 
 
 
 
 

Sales

Growthquarterly 5.41%
 
 
 
 
 
 
Growthannually 30.96%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.